This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

South Korean blood glucose monitor maker fined for resale price maintenance

( May 7, 2025, 04:13 GMT | Official Statement) -- MLex summary: i-Sens, a South Korean blood glucose monitor maker, has been fined 256 million won ($183,000) by the country’s competition regulator for restricting resellers from setting their own prices and withholding supplies for those that sold products below a certain price. The Korea Fair Trade Commission found that the company fixed prices for parts of its blood glucose monitors since 2018 and raised supply prices or suspended supply to resellers that failed to meet with its pricing policy. The company also monitored online prices through an intermediary, created a blacklist of noncompliant resellers and restricted supply to those that did not adhere to its pricing policy. The statement, in Korean, is attached....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents

Related Sections